Arrhythmias and Sudden Cardiac Death in Beta-Thalassemia Major Patients: Noninvasive Diagnostic Tools and Early Markers

Beta-thalassemias are a group of inherited, autosomal recessive diseases, characterized by reduced or absent synthesis of beta-globin chains of the hemoglobin tetramer, resulting in variable phenotypes, ranging from clinically asymptomatic individuals to severe anemia. Three main forms have been des...

Full description

Saved in:
Bibliographic Details
Main Authors: Vincenzo Russo, Enrico Melillo, Andrea A. Papa, Anna Rago, Celeste Chamberland, Gerardo Nigro
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.1155/2019/9319832
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548090103463936
author Vincenzo Russo
Enrico Melillo
Andrea A. Papa
Anna Rago
Celeste Chamberland
Gerardo Nigro
author_facet Vincenzo Russo
Enrico Melillo
Andrea A. Papa
Anna Rago
Celeste Chamberland
Gerardo Nigro
author_sort Vincenzo Russo
collection DOAJ
description Beta-thalassemias are a group of inherited, autosomal recessive diseases, characterized by reduced or absent synthesis of beta-globin chains of the hemoglobin tetramer, resulting in variable phenotypes, ranging from clinically asymptomatic individuals to severe anemia. Three main forms have been described: heterozygotes, homozygotes β+, and homozygotes β°. Beta-thalassemia major (β-TM), the most serious form, is characterized by an absent synthesis of globin chains that are essential for hemoglobin formation, causing chronic hemolytic anemia. Cardiac complications represent a leading cause of mortality in β-TM patients, although an important and progressive increase of life expectancy has been demonstrated after the introduction of chelating therapies. Iron overload is the primary factor of cardiac damage resulting in thalassemic cardiomyopathy, in which diastolic dysfunction usually happens before systolic impairment and overt heart failure (HF). Although iron-induced cardiomyopathy is slowly progressive and it usually takes several decades for clinical and laboratory features of cardiac dysfunction to manifest, arrhythmias or sudden death may be present without signs of cardiac disease and only if myocardial siderosis is present. Careful analysis of electrocardiograms and other diagnostic tools may help in early identification of high-risk β-TM patients for arrhythmias and sudden cardiac death.
format Article
id doaj-art-d9b1a1e038ce4bb1bc758612424a2b15
institution Kabale University
issn 2090-8016
2090-0597
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Cardiology Research and Practice
spelling doaj-art-d9b1a1e038ce4bb1bc758612424a2b152025-02-03T06:42:17ZengWileyCardiology Research and Practice2090-80162090-05972019-01-01201910.1155/2019/93198329319832Arrhythmias and Sudden Cardiac Death in Beta-Thalassemia Major Patients: Noninvasive Diagnostic Tools and Early MarkersVincenzo Russo0Enrico Melillo1Andrea A. Papa2Anna Rago3Celeste Chamberland4Gerardo Nigro5Chair of Cardiology, Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Monaldi Hospital, Naples, ItalyChair of Cardiology, Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Monaldi Hospital, Naples, ItalyChair of Cardiology, Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Monaldi Hospital, Naples, ItalyChair of Cardiology, Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Monaldi Hospital, Naples, ItalyDepartment of History and Philosophy, Roosevelt University, Chicago, Illinois, USAChair of Cardiology, Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Monaldi Hospital, Naples, ItalyBeta-thalassemias are a group of inherited, autosomal recessive diseases, characterized by reduced or absent synthesis of beta-globin chains of the hemoglobin tetramer, resulting in variable phenotypes, ranging from clinically asymptomatic individuals to severe anemia. Three main forms have been described: heterozygotes, homozygotes β+, and homozygotes β°. Beta-thalassemia major (β-TM), the most serious form, is characterized by an absent synthesis of globin chains that are essential for hemoglobin formation, causing chronic hemolytic anemia. Cardiac complications represent a leading cause of mortality in β-TM patients, although an important and progressive increase of life expectancy has been demonstrated after the introduction of chelating therapies. Iron overload is the primary factor of cardiac damage resulting in thalassemic cardiomyopathy, in which diastolic dysfunction usually happens before systolic impairment and overt heart failure (HF). Although iron-induced cardiomyopathy is slowly progressive and it usually takes several decades for clinical and laboratory features of cardiac dysfunction to manifest, arrhythmias or sudden death may be present without signs of cardiac disease and only if myocardial siderosis is present. Careful analysis of electrocardiograms and other diagnostic tools may help in early identification of high-risk β-TM patients for arrhythmias and sudden cardiac death.http://dx.doi.org/10.1155/2019/9319832
spellingShingle Vincenzo Russo
Enrico Melillo
Andrea A. Papa
Anna Rago
Celeste Chamberland
Gerardo Nigro
Arrhythmias and Sudden Cardiac Death in Beta-Thalassemia Major Patients: Noninvasive Diagnostic Tools and Early Markers
Cardiology Research and Practice
title Arrhythmias and Sudden Cardiac Death in Beta-Thalassemia Major Patients: Noninvasive Diagnostic Tools and Early Markers
title_full Arrhythmias and Sudden Cardiac Death in Beta-Thalassemia Major Patients: Noninvasive Diagnostic Tools and Early Markers
title_fullStr Arrhythmias and Sudden Cardiac Death in Beta-Thalassemia Major Patients: Noninvasive Diagnostic Tools and Early Markers
title_full_unstemmed Arrhythmias and Sudden Cardiac Death in Beta-Thalassemia Major Patients: Noninvasive Diagnostic Tools and Early Markers
title_short Arrhythmias and Sudden Cardiac Death in Beta-Thalassemia Major Patients: Noninvasive Diagnostic Tools and Early Markers
title_sort arrhythmias and sudden cardiac death in beta thalassemia major patients noninvasive diagnostic tools and early markers
url http://dx.doi.org/10.1155/2019/9319832
work_keys_str_mv AT vincenzorusso arrhythmiasandsuddencardiacdeathinbetathalassemiamajorpatientsnoninvasivediagnostictoolsandearlymarkers
AT enricomelillo arrhythmiasandsuddencardiacdeathinbetathalassemiamajorpatientsnoninvasivediagnostictoolsandearlymarkers
AT andreaapapa arrhythmiasandsuddencardiacdeathinbetathalassemiamajorpatientsnoninvasivediagnostictoolsandearlymarkers
AT annarago arrhythmiasandsuddencardiacdeathinbetathalassemiamajorpatientsnoninvasivediagnostictoolsandearlymarkers
AT celestechamberland arrhythmiasandsuddencardiacdeathinbetathalassemiamajorpatientsnoninvasivediagnostictoolsandearlymarkers
AT gerardonigro arrhythmiasandsuddencardiacdeathinbetathalassemiamajorpatientsnoninvasivediagnostictoolsandearlymarkers